The involvement of tumour necrosis factor-related apoptosis inducing ligand (TRAIL) in atherosclerosis

被引：0
|
作者：
George, J [1 ]
Michowitz, Y [1 ]
Goldstein, E [1 ]
Keren, G [1 ]
机构：
[1] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
来源：
EUROPEAN HEART JOURNAL | 2004年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296 / 296
页数：1
相关论文
共 50 条
  • [41] Tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis is dependent on activation of cysteine and serine proteases
    Park, IC
    Park, MJ
    Woo, SH
    Lee, KH
    Lee, SH
    Rhee, CH
    Hong, SI
    CYTOKINE, 2001, 15 (03) : 166 - 170
  • [42] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells
    Nesterov, A
    Ivashchenko, Y
    Kraft, AS
    ONCOGENE, 2002, 21 (07) : 1135 - 1140
  • [43] The role of dietary polyphenols in tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis for cancer chemoprevention
    Szliszka, Ewelina
    Krol, Wojciech
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2011, 20 (01) : 63 - 69
  • [44] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells
    Alexandre Nesterov
    Yuri Ivashchenko
    Andrew S Kraft
    Oncogene, 2002, 21 : 1135 - 1140
  • [45] Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis
    Hofbauer, L. C.
    Schoppet, M.
    Christ, M.
    Teichmann, J.
    Lange, U.
    RHEUMATOLOGY, 2006, 45 (10) : 1218 - 1222
  • [46] Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: A protector or culprit?
    Cheng, Wen
    Zhao, Yuxia
    Wang, Shuangxi
    Jiang, Fan
    VASCULAR PHARMACOLOGY, 2014, 63 (03) : 135 - 144
  • [47] Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis
    McGrath, Emmet E.
    Lawrie, Allan
    Marriott, Helen M.
    Mercer, Paul
    Cross, Simon S.
    Arnold, Nadine
    Singleton, Vanessa
    Thompson, Alfred A. R.
    Walmsley, Sarah R.
    Renshaw, Stephen A.
    Sabroe, Ian
    Chambers, Rachel C.
    Dockrell, David H.
    Whyte, Moira K. B.
    THORAX, 2012, 67 (09) : 796 - 803
  • [48] Interaction between tumour necrosis factor-related apoptosis inducing ligand & osteoprotegerin in acute coronary syndromes
    Watt, V.
    Ray, K. K.
    Francis, S. E.
    Crossman, D. C.
    EUROPEAN HEART JOURNAL, 2006, 27 : 229 - 229
  • [49] Involvement of tumor necrosis factor-retated apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases
    Saitou, Y
    Shiraki, K
    Fuke, H
    Inoue, T
    Miyashita, K
    Yamanaka, Y
    Yamaguchi, Y
    Yamamoto, N
    Ito, K
    Sugimoto, K
    Nakano, T
    HUMAN PATHOLOGY, 2005, 36 (10) : 1066 - 1073
  • [50] Prognostic Value of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors in Renal Cell Cancer
    Macher-Goeppinger, Stephan
    Aulmann, Sebastian
    Tagscherer, Katrin E.
    Wagener, Nina
    Haferkamp, Axel
    Penzel, Roland
    Brauckhoff, Antje
    Hohenfellner, Markus
    Sykora, Jaromir
    Walczak, Henning
    Teh, Bin T.
    Autschbach, Frank
    Herpel, Esther
    Schirmacher, Peter
    Roth, Wilfried
    CLINICAL CANCER RESEARCH, 2009, 15 (02) : 650 - 659
12345